Global Monoclonal Antibody Biologics and Biosimilars Market Growth (Status and Outlook) 2026-2032
The global Monoclonal Antibody Biologics and Biosimilars market size is predicted to grow from US$ 280190 million in 2025 to US$ 627650 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body?s own antibodies, monoclonal antibodies recognize specific targets.
The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.
LPI (LP Information)' newest research report, the ?Monoclonal Antibody Biologics and Biosimilars Industry Forecast? looks at past sales and reviews total world Monoclonal Antibody Biologics and Biosimilars sales in 2025, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Biologics and Biosimilars sales for 2026 through 2032. With Monoclonal Antibody Biologics and Biosimilars sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Biologics and Biosimilars industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Biologics and Biosimilars landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monoclonal Antibody Biologics and Biosimilars portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Monoclonal Antibody Biologics and Biosimilars market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Biologics and Biosimilars and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Biologics and Biosimilars.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Biologics and Biosimilars market by product type, application, key players and key regions and countries.
Segmentation by Type:
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body?s own antibodies, monoclonal antibodies recognize specific targets.
The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.
LPI (LP Information)' newest research report, the ?Monoclonal Antibody Biologics and Biosimilars Industry Forecast? looks at past sales and reviews total world Monoclonal Antibody Biologics and Biosimilars sales in 2025, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Biologics and Biosimilars sales for 2026 through 2032. With Monoclonal Antibody Biologics and Biosimilars sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Biologics and Biosimilars industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Biologics and Biosimilars landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monoclonal Antibody Biologics and Biosimilars portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Monoclonal Antibody Biologics and Biosimilars market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Biologics and Biosimilars and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Biologics and Biosimilars.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Biologics and Biosimilars market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Biologics
- Biosimilars
- Cancer
- Autoimmune Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Innovent Biologics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size (2021-2032)
2.1.2 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Monoclonal Antibody Biologics and Biosimilars by Country/Region (2021, 2025 & 2032)
2.2 Monoclonal Antibody Biologics and Biosimilars Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.2.3 Monoclonal Antibody Biologics and Biosimilars Market Size by Type
2.2.3.1 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
2.3 Monoclonal Antibody Biologics and Biosimilars Segment by Application
2.3.1 Cancer
2.3.2 Autoimmune Disease
2.3.3 Other
2.3.4 Monoclonal Antibody Biologics and Biosimilars Market Size by Application
2.3.4.1 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
3 MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS MARKET SIZE BY PLAYER
3.1 Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Player
3.1.1 Global Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2021-2026)
3.1.2 Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player (2021-2026)
3.2 Global Monoclonal Antibody Biologics and Biosimilars Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS BY REGION
4.1 Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026)
4.2 Global Monoclonal Antibody Biologics and Biosimilars Annual Revenue by Country/Region (2021-2026)
4.3 Americas Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.4 APAC Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.5 Europe Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.6 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026)
5.2 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
5.3 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026)
6.2 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
6.3 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026)
7.2 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
7.3 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars by Region (2021-2026)
8.2 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
8.3 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS MARKET FORECAST
10.1 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.1.1 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.1.2 Americas Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.3 APAC Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.4 Europe Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.5 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Forecast
10.2 Americas Monoclonal Antibody Biologics and Biosimilars Forecast by Country (2027-2032)
10.2.1 United States Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.2 Canada Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.3 Mexico Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.4 Brazil Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3 APAC Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.3.1 China Monoclonal Antibody Biologics and Biosimilars Market Forecast
10.3.2 Japan Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.3 Korea Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.4 Southeast Asia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.5 India Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.6 Australia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4 Europe Monoclonal Antibody Biologics and Biosimilars Forecast by Country (2027-2032)
10.4.1 Germany Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.2 France Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.3 UK Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.4 Italy Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.5 Russia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.5.1 Egypt Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.2 South Africa Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.3 Israel Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.4 Turkey Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.6 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Type (2027-2032)
10.7 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Monoclonal Antibody Biologics and Biosimilars Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Monoclonal Antibody Biologics and Biosimilars Product Offered
11.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Monoclonal Antibody Biologics and Biosimilars Product Offered
11.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Monoclonal Antibody Biologics and Biosimilars Product Offered
11.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Monoclonal Antibody Biologics and Biosimilars Product Offered
11.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product Offered
11.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Monoclonal Antibody Biologics and Biosimilars Product Offered
11.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Offered
11.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Eli Lilly Main Business Overview
11.7.5 Eli Lilly Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Monoclonal Antibody Biologics and Biosimilars Product Offered
11.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Monoclonal Antibody Biologics and Biosimilars Product Offered
11.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Biogen
11.10.1 Biogen Company Information
11.10.2 Biogen Monoclonal Antibody Biologics and Biosimilars Product Offered
11.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Biogen Main Business Overview
11.10.5 Biogen Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Monoclonal Antibody Biologics and Biosimilars Product Offered
11.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Sobi
11.12.1 Sobi Company Information
11.12.2 Sobi Monoclonal Antibody Biologics and Biosimilars Product Offered
11.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sobi Main Business Overview
11.12.5 Sobi Latest Developments
11.13 3SBIO
11.13.1 3SBIO Company Information
11.13.2 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Offered
11.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 3SBIO Main Business Overview
11.13.5 3SBIO Latest Developments
11.14 Innovent Biologics
11.14.1 Innovent Biologics Company Information
11.14.2 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Offered
11.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Innovent Biologics Main Business Overview
11.14.5 Innovent Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size (2021-2032)
2.1.2 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Monoclonal Antibody Biologics and Biosimilars by Country/Region (2021, 2025 & 2032)
2.2 Monoclonal Antibody Biologics and Biosimilars Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.2.3 Monoclonal Antibody Biologics and Biosimilars Market Size by Type
2.2.3.1 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
2.3 Monoclonal Antibody Biologics and Biosimilars Segment by Application
2.3.1 Cancer
2.3.2 Autoimmune Disease
2.3.3 Other
2.3.4 Monoclonal Antibody Biologics and Biosimilars Market Size by Application
2.3.4.1 Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
3 MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS MARKET SIZE BY PLAYER
3.1 Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Player
3.1.1 Global Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2021-2026)
3.1.2 Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player (2021-2026)
3.2 Global Monoclonal Antibody Biologics and Biosimilars Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS BY REGION
4.1 Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026)
4.2 Global Monoclonal Antibody Biologics and Biosimilars Annual Revenue by Country/Region (2021-2026)
4.3 Americas Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.4 APAC Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.5 Europe Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
4.6 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026)
5.2 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
5.3 Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026)
6.2 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
6.3 APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026)
7.2 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
7.3 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars by Region (2021-2026)
8.2 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026)
8.3 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS MARKET FORECAST
10.1 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.1.1 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.1.2 Americas Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.3 APAC Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.4 Europe Monoclonal Antibody Biologics and Biosimilars Forecast
10.1.5 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Forecast
10.2 Americas Monoclonal Antibody Biologics and Biosimilars Forecast by Country (2027-2032)
10.2.1 United States Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.2 Canada Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.3 Mexico Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.2.4 Brazil Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3 APAC Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.3.1 China Monoclonal Antibody Biologics and Biosimilars Market Forecast
10.3.2 Japan Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.3 Korea Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.4 Southeast Asia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.5 India Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.3.6 Australia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4 Europe Monoclonal Antibody Biologics and Biosimilars Forecast by Country (2027-2032)
10.4.1 Germany Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.2 France Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.3 UK Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.4 Italy Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.4.5 Russia Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Forecast by Region (2027-2032)
10.5.1 Egypt Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.2 South Africa Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.3 Israel Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.5.4 Turkey Market Monoclonal Antibody Biologics and Biosimilars Forecast
10.6 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Type (2027-2032)
10.7 Global Monoclonal Antibody Biologics and Biosimilars Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Monoclonal Antibody Biologics and Biosimilars Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Monoclonal Antibody Biologics and Biosimilars Product Offered
11.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Monoclonal Antibody Biologics and Biosimilars Product Offered
11.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Monoclonal Antibody Biologics and Biosimilars Product Offered
11.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Monoclonal Antibody Biologics and Biosimilars Product Offered
11.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product Offered
11.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Monoclonal Antibody Biologics and Biosimilars Product Offered
11.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Offered
11.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Eli Lilly Main Business Overview
11.7.5 Eli Lilly Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Monoclonal Antibody Biologics and Biosimilars Product Offered
11.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Monoclonal Antibody Biologics and Biosimilars Product Offered
11.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Biogen
11.10.1 Biogen Company Information
11.10.2 Biogen Monoclonal Antibody Biologics and Biosimilars Product Offered
11.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Biogen Main Business Overview
11.10.5 Biogen Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Monoclonal Antibody Biologics and Biosimilars Product Offered
11.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Sobi
11.12.1 Sobi Company Information
11.12.2 Sobi Monoclonal Antibody Biologics and Biosimilars Product Offered
11.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sobi Main Business Overview
11.12.5 Sobi Latest Developments
11.13 3SBIO
11.13.1 3SBIO Company Information
11.13.2 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Offered
11.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 3SBIO Main Business Overview
11.13.5 3SBIO Latest Developments
11.14 Innovent Biologics
11.14.1 Innovent Biologics Company Information
11.14.2 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Offered
11.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Innovent Biologics Main Business Overview
11.14.5 Innovent Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Monoclonal Antibody Biologics and Biosimilars Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Biologics
Table 4. Major Players of Biosimilars
Table 5. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Table 8. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Table 11. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player (2021-2026)
Table 13. Monoclonal Antibody Biologics and Biosimilars Key Players Head office and Products Offered
Table 14. Monoclonal Antibody Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Table 19. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country (2021-2026)
Table 23. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Table 25. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Table 27. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Table 29. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country (2021-2026)
Table 33. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Biologics and Biosimilars
Table 39. Key Market Challenges & Risks of Monoclonal Antibody Biologics and Biosimilars
Table 40. Key Industry Trends of Monoclonal Antibody Biologics and Biosimilars
Table 41. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 46. Roche Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 47. Roche Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Amgen Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 51. Amgen Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 52. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Amgen Main Business
Table 54. Amgen Latest Developments
Table 55. AbbVie Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 56. AbbVie Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 57. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Sanofi Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 61. Sanofi Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 62. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sanofi Main Business
Table 64. Sanofi Latest Developments
Table 65. Johnson & Johnson Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 66. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 67. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Latest Developments
Table 70. Pfizer Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 71. Pfizer Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 72. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Eli Lilly Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 76. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 77. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Eli Lilly Main Business
Table 79. Eli Lilly Latest Developments
Table 80. Novartis Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 81. Novartis Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 82. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Merck Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 86. Merck Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 87. Merck Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Biogen Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 91. Biogen Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 92. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Biogen Main Business
Table 94. Biogen Latest Developments
Table 95. Celltrion Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 96. Celltrion Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 97. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Celltrion Main Business
Table 99. Celltrion Latest Developments
Table 100. Sobi Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 101. Sobi Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 102. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Sobi Main Business
Table 104. Sobi Latest Developments
Table 105. 3SBIO Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 106. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 107. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. 3SBIO Main Business
Table 109. 3SBIO Latest Developments
Table 110. Innovent Biologics Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 111. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 112. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Innovent Biologics Main Business
Table 114. Innovent Biologics Latest Developments
Table 1. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Monoclonal Antibody Biologics and Biosimilars Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Biologics
Table 4. Major Players of Biosimilars
Table 5. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Table 8. Monoclonal Antibody Biologics and Biosimilars Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Table 11. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player (2021-2026)
Table 13. Monoclonal Antibody Biologics and Biosimilars Key Players Head office and Products Offered
Table 14. Monoclonal Antibody Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Table 19. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country (2021-2026)
Table 23. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Table 25. Americas Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Table 27. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Table 29. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country (2021-2026)
Table 33. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Biologics and Biosimilars
Table 39. Key Market Challenges & Risks of Monoclonal Antibody Biologics and Biosimilars
Table 40. Key Industry Trends of Monoclonal Antibody Biologics and Biosimilars
Table 41. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Monoclonal Antibody Biologics and Biosimilars Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 46. Roche Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 47. Roche Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Amgen Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 51. Amgen Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 52. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Amgen Main Business
Table 54. Amgen Latest Developments
Table 55. AbbVie Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 56. AbbVie Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 57. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Sanofi Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 61. Sanofi Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 62. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sanofi Main Business
Table 64. Sanofi Latest Developments
Table 65. Johnson & Johnson Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 66. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 67. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Latest Developments
Table 70. Pfizer Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 71. Pfizer Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 72. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Eli Lilly Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 76. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 77. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Eli Lilly Main Business
Table 79. Eli Lilly Latest Developments
Table 80. Novartis Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 81. Novartis Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 82. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Merck Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 86. Merck Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 87. Merck Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Biogen Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 91. Biogen Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 92. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Biogen Main Business
Table 94. Biogen Latest Developments
Table 95. Celltrion Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 96. Celltrion Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 97. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Celltrion Main Business
Table 99. Celltrion Latest Developments
Table 100. Sobi Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 101. Sobi Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 102. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Sobi Main Business
Table 104. Sobi Latest Developments
Table 105. 3SBIO Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 106. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 107. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. 3SBIO Main Business
Table 109. 3SBIO Latest Developments
Table 110. Innovent Biologics Details, Company Type, Monoclonal Antibody Biologics and Biosimilars Area Served and Its Competitors
Table 111. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Offered
Table 112. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Innovent Biologics Main Business
Table 114. Innovent Biologics Latest Developments
LIST OF FIGURES
Figure 1. Monoclonal Antibody Biologics and Biosimilars Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Monoclonal Antibody Biologics and Biosimilars Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country/Region (2025)
Figure 8. Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type in 2025
Figure 10. Monoclonal Antibody Biologics and Biosimilars in Cancer
Figure 11. Global Monoclonal Antibody Biologics and Biosimilars Market: Cancer (2021-2026) & ($ millions)
Figure 12. Monoclonal Antibody Biologics and Biosimilars in Autoimmune Disease
Figure 13. Global Monoclonal Antibody Biologics and Biosimilars Market: Autoimmune Disease (2021-2026) & ($ millions)
Figure 14. Monoclonal Antibody Biologics and Biosimilars in Other
Figure 15. Global Monoclonal Antibody Biologics and Biosimilars Market: Other (2021-2026) & ($ millions)
Figure 16. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application in 2025
Figure 17. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player in 2025
Figure 18. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Figure 19. Americas Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 20. APAC Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 21. Europe Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 23. Americas Monoclonal Antibody Biologics and Biosimilars Value Market Share by Country in 2025
Figure 24. United States Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region in 2025
Figure 29. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 30. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 31. China Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 35. India Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country in 2025
Figure 38. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 39. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 40. Germany Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 41. France Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 54. APAC Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 55. Europe Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 57. United States Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 58. Canada Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 59. Mexico Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 60. Brazil Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 61. China Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 62. Japan Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 63. Korea Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 65. India Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 66. Australia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 67. Germany Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 68. France Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 69. UK Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 70. Italy Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 71. Russia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 72. Egypt Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 73. South Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 74. Israel Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 75. Turkey Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 76. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 1. Monoclonal Antibody Biologics and Biosimilars Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Monoclonal Antibody Biologics and Biosimilars Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country/Region (2025)
Figure 8. Monoclonal Antibody Biologics and Biosimilars Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type in 2025
Figure 10. Monoclonal Antibody Biologics and Biosimilars in Cancer
Figure 11. Global Monoclonal Antibody Biologics and Biosimilars Market: Cancer (2021-2026) & ($ millions)
Figure 12. Monoclonal Antibody Biologics and Biosimilars in Autoimmune Disease
Figure 13. Global Monoclonal Antibody Biologics and Biosimilars Market: Autoimmune Disease (2021-2026) & ($ millions)
Figure 14. Monoclonal Antibody Biologics and Biosimilars in Other
Figure 15. Global Monoclonal Antibody Biologics and Biosimilars Market: Other (2021-2026) & ($ millions)
Figure 16. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application in 2025
Figure 17. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Player in 2025
Figure 18. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Figure 19. Americas Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 20. APAC Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 21. Europe Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2021-2026 ($ millions)
Figure 23. Americas Monoclonal Antibody Biologics and Biosimilars Value Market Share by Country in 2025
Figure 24. United States Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region in 2025
Figure 29. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 30. APAC Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 31. China Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 35. India Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Country in 2025
Figure 38. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 39. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 40. Germany Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 41. France Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Monoclonal Antibody Biologics and Biosimilars Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 54. APAC Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 55. Europe Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 57. United States Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 58. Canada Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 59. Mexico Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 60. Brazil Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 61. China Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 62. Japan Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 63. Korea Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 65. India Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 66. Australia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 67. Germany Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 68. France Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 69. UK Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 70. Italy Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 71. Russia Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 72. Egypt Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 73. South Africa Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 74. Israel Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 75. Turkey Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
Figure 76. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Monoclonal Antibody Biologics and Biosimilars Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Monoclonal Antibody Biologics and Biosimilars Market Size 2027-2032 ($ millions)
